Antithymic immune factor in schizophrenia. A World Health Organization study.
Six WHO Collaborating Centre took part in the study of the antithymic activity of blood sera of patients suffering from schizophrenia. Blood serum specimens from 118 schizophrenic patients and 62 mentally healthy donors were investigated. Statistically significant differences between schizophrenic patients and the controls were found (p < 0.05). It is probable that as with other biological phenomena described in schizophrenia, antithymic activity is one of the biological factors, in combination with other factors, predisposing towards the development of the schizophrenic process.
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum; D003601:Cytotoxicity Tests, Immunologic; D003718:Denmark; D004739:England; D005860:Germany, West; D006801:Humans; D008396:Maryland; D008875:Middle Aged; D012559:Schizophrenia / Q000276:immunology*; D013557:Switzerland; D013601:T-Lymphocytes / Q000276:immunology*; D014586:USSR; D014944:World Health Organization
D000961:Antilymphocyte Serum